Abstract
BL Zuraw, PJ Busse, M White. N Engl J Med. 2010;363(6):513–522 To determine the efficacy of nanofiltered C1 inhibitor concentrate in the management of hereditary angioedema (HAE). Subjects were from 2 studies; the lowest age was 6 years (median age: 36 years). Both studies compared an intravenous dose of 1000 U of nanofiltered C1 inhibitor concentrate in the management of HAE. The first study end point was the time to unequivocal relief of symptoms during an acute attack of HAE. The second study was …
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
